News
EPIX
0.2012
-0.92%
-0.0019
XOMA Royalty reports Q3 revenue of $9.4 million and year-to-date revenue of $38.4 million
Reuters · 11/12 12:30
*News On Essa Pharma Inc. (EPIX) Now Under XEN.XX
Dow Jones · 10/09 21:08
ESSA Pharma Completes Acquisition by XenoTherapeutics
TipRanks · 10/09 11:29
XenoTherapeutics completes acquisition of ESSA Pharma with shareholders to receive cash and contingent value rights
Reuters · 10/09 11:01
ESSA Pharma Inc to be delisted from Nasdaq following acquisition by XenoTherapeutics
Reuters · 10/09 11:01
ESSA Pharma Securityholders Approve Acquisition by XenoTherapeutics
Barchart · 10/07 16:48
*ESSA Pharma: Completion of Deal Expected On or About Thursday
Dow Jones · 10/06 21:23
*ESSA Pharma Securityholders Approve Acquisition by XenoTherapeutics
Dow Jones · 10/06 21:23
Essa Pharma shareholders approve acquisition by XenoTherapeutics
TipRanks · 10/06 21:20
ESSA Pharma Inc. Held Special Meeting of Securityholders Regarding Acquisition by XenoTherapeutics
Reuters · 10/06 21:15
ESSA SECURITYHOLDERS APPROVE ACQUISITION BY XENOTHERAPEUTICS
Reuters · 10/06 21:15
Weekly Report: what happened at EPIX last week (0929-1003)?
Weekly Report · 10/06 10:01
ESSA Pharma Faces Class Action Lawsuit in California
Barchart · 10/04 05:34
ESSA Pharma Receives Court Approval for Acquisition
TipRanks · 09/30 21:01
Essa Pharma provides update on combination agreement with Xeno
TipRanks · 09/30 20:40
ESSA Pharma Received An Amended Interim Order From The Supreme Court Of British Columbia On September 25, 2025; The Amended Interim Order Approves The Previously Announced Date For ESSA's Special Meeting Of The Holders Of Common Shares Of The Company, Optionholders And Warrantholders Of October 3, 2025
Benzinga · 09/30 20:37
ESSA PHARMA INC. PROVIDES UPDATE ON ITS APPLICATION TO THE SUPREME COURT OF BRITISH COLUMBIA FOR AMENDED INTERIM ORDER
Reuters · 09/30 20:31
ESSA Pharma Provides Update on Special Meeting and Court Approvals for XenoTherapeutics Acquisition
Reuters · 09/30 20:31
More
Webull provides a variety of real-time EPIX stock news. You can receive the latest news about Essa Pharma through multiple platforms. This information may help you make smarter investment decisions.
About EPIX
ESSA Pharma Inc. is a Canada-based pharmaceutical company that was previously focused on developing therapies for the treatment of patients with prostate cancer. The Company is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.